BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 32257057)

  • 1. The quaternary assembly of KRas4B with Raf-1 at the membrane.
    Jang H; Zhang M; Nussinov R
    Comput Struct Biotechnol J; 2020; 18():737-748. PubMed ID: 32257057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raf-1 Cysteine-Rich Domain Increases the Affinity of K-Ras/Raf at the Membrane, Promoting MAPK Signaling.
    Li S; Jang H; Zhang J; Nussinov R
    Structure; 2018 Mar; 26(3):513-525.e2. PubMed ID: 29429878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring CRD mobility during RAS/RAF engagement at the membrane.
    Nguyen K; López CA; Neale C; Van QN; Carpenter TS; Di Natale F; Travers T; Tran TH; Chan AH; Bhatia H; Frank PH; Tonelli M; Zhang X; Gulten G; Reddy T; Burns V; Oppelstrup T; Hengartner N; Simanshu DK; Bremer PT; Chen D; Glosli JN; Shrestha R; Turbyville T; Streitz FH; Nissley DV; Ingólfsson HI; Stephen AG; Lightstone FC; Gnanakaran S
    Biophys J; 2022 Oct; 121(19):3630-3650. PubMed ID: 35778842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal Structure Reveals the Full Ras-Raf Interface and Advances Mechanistic Understanding of Raf Activation.
    Cookis T; Mattos C
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reconstitution and characterization of BRAF in complex with 14-3-3 and KRAS4B on nanodiscs.
    Liu NF; Enomoto M; Marshall CB; Ikura M
    Protein Sci; 2024 Jun; 33(6):e5016. PubMed ID: 38747381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivalent assembly of KRAS with the RAS-binding and cysteine-rich domains of CRAF on the membrane.
    Fang Z; Lee KY; Huo KG; Gasmi-Seabrook G; Zheng L; Moghal N; Tsao MS; Ikura M; Marshall CB
    Proc Natl Acad Sci U S A; 2020 Jun; 117(22):12101-12108. PubMed ID: 32414921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Raf promotes dimerization of the Ras G-domain with increased allosteric connections.
    Packer MR; Parker JA; Chung JK; Li Z; Lee YK; Cookis T; Guterres H; Alvarez S; Hossain MA; Donnelly DP; Agar JN; Makowski L; Buck M; Groves JT; Mattos C
    Proc Natl Acad Sci U S A; 2021 Mar; 118(10):. PubMed ID: 33653954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Nanoclustering essential for all oncogenic KRas pathways? Can it explain why wild-type KRas can inhibit its oncogenic variant?
    Nussinov R; Tsai CJ; Jang H
    Semin Cancer Biol; 2019 Feb; 54():114-120. PubMed ID: 29307569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic Ras Isoforms Signaling Specificity at the Membrane.
    Nussinov R; Tsai CJ; Jang H
    Cancer Res; 2018 Feb; 78(3):593-602. PubMed ID: 29273632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the Spatial Organization of Raf Isoforms Interacting with K-Ras4B in the Lipid Membrane.
    Li L; Möbitz S; Winter R
    Langmuir; 2020 Jun; 36(21):5944-5953. PubMed ID: 32390436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A "Tug of War" Maintains a Dynamic Protein-Membrane Complex: Molecular Dynamics Simulations of C-Raf RBD-CRD Bound to K-Ras4B at an Anionic Membrane.
    Li ZL; Prakash P; Buck M
    ACS Cent Sci; 2018 Feb; 4(2):298-305. PubMed ID: 29532030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular recognition of RAS/RAF complex at the membrane: Role of RAF cysteine-rich domain.
    Travers T; López CA; Van QN; Neale C; Tonelli M; Stephen AG; Gnanakaran S
    Sci Rep; 2018 May; 8(1):8461. PubMed ID: 29855542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles.
    Liao TJ; Jang H; Fushman D; Nussinov R
    Biophys J; 2018 Aug; 115(4):629-641. PubMed ID: 30097175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allosteric effects of the oncogenic RasQ61L mutant on Raf-RBD.
    Fetics SK; Guterres H; Kearney BM; Buhrman G; Ma B; Nussinov R; Mattos C
    Structure; 2015 Mar; 23(3):505-516. PubMed ID: 25684575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anionic Lipids Impact RAS-Binding Site Accessibility and Membrane Binding Affinity of CRAF RBD-CRD.
    Travers T; López CA; Agamasu C; Hettige JJ; Messing S; García AE; Stephen AG; Gnanakaran S
    Biophys J; 2020 Aug; 119(3):525-538. PubMed ID: 32649863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How Anionic Lipids Affect Spatiotemporal Properties of KRAS4B on Model Membranes.
    Ngo VA; Sarkar S; Neale C; Garcia AE
    J Phys Chem B; 2020 Jul; 124(26):5434-5453. PubMed ID: 32438809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane Composition and Raf[CRD]-Membrane Attachment Are Driving Forces for K-Ras4B Dimer Stability.
    Andreadelis I; Kiriakidi S; Lamprakis C; Theodoropoulou A; Doerr S; Chatzigoulas A; Manchester J; Velez-Vega C; Duca JS; Cournia Z
    J Phys Chem B; 2022 Feb; 126(7):1504-1519. PubMed ID: 35142524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-associated Ras dimers are isoform-specific: K-Ras dimers differ from H-Ras dimers.
    Jang H; Muratcioglu S; Gursoy A; Keskin O; Nussinov R
    Biochem J; 2016 Jun; 473(12):1719-32. PubMed ID: 27057007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-Raf autoinhibition in the presence and absence of 14-3-3.
    Zhang M; Jang H; Li Z; Sacks DB; Nussinov R
    Structure; 2021 Jul; 29(7):768-777.e2. PubMed ID: 33711246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural insights into the complex of oncogenic KRas4B
    Tariq M; Ikeya T; Togashi N; Fairall L; Kamei S; Mayooramurugan S; Abbott LR; Hasan A; Bueno-Alejo C; Sukegawa S; Romartinez-Alonso B; Muro Campillo MA; Hudson AJ; Ito Y; Schwabe JW; Dominguez C; Tanaka K
    Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37833074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.